| Name | shugoshin 2 |
| Description | Predicted to be involved in meiotic sister chromatid cohesion. Predicted to act upstream of or within several processes, including meiotic nuclear division; meiotic sister chromatid cohesion; and positive regulation of maintenance of meiotic sister chromatid cohesion, centromeric. Located in chromosome, centromeric region and nuclear body. Part of mitotic cohesin complex. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSGO2 is a critical centromeric protein that orchestrates multiple aspects of faithful chromosome segregation. In mitotic cells, SGO2 is phosphorylated by Aurora B at distinct regions, a modification that distinctively promotes its binding to PP2A for centromeric protection of cohesin and to MCAK for the regulation of chromosome congression. In addition, SGO2 can form a complex with MAD2, thereby acting as a competitive inhibitor of separase—a function that becomes especially important when the canonical separase inhibitor, securin, is absent. This multiplicity of roles safeguards accurate sister chromatid separation even under conditions of perturbed mitosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its functions in mitosis, SGO2 is essential in germ cells where it maintains cohesin integrity during meiosis. Loss-of-function mutations in SGO2 have been associated with primary ovarian insufficiency, suggesting that SGO2 is critical for fertility. Furthermore, additional regulatory mechanisms involving the chaperone SET underscore the importance of precisely timed SGO2 eviction from centromeres to facilitate proper chromatid resolution during cell division. Such mechanisms highlight a complex network that governs SGO2 activity via interactions with other key regulators, including PP2A antagonism."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAberrant expression and function of SGO2 have also been implicated in oncogenesis. Elevated SGO2 levels have been observed in gliomas and hepatocellular carcinoma, where SGO2 expression correlates with higher tumor grades and poorer survival outcomes. In prostate cancer models, SGO2 has been shown to stabilize RAB1A by inhibiting its ubiquitination, thereby promoting cell proliferation, migration, and modulating the tumor microenvironment. These findings collectively not only reinforce the centrality of SGO2 in regulating cell division but also spotlight its potential as a prognostic biomarker and therapeutic target across a range of malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yuji Tanno, Tomoya S Kitajima, Takashi Honda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation of mammalian Sgo2 by Aurora B recruits PP2A and MCAK to centromeres."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.1945310"}], "href": "https://doi.org/10.1101/gad.1945310"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20889715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20889715"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ahmed Rattani, Magda Wolna, Mickael Ploquin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sgol2 provides a regulatory platform that coordinates essential cell cycle processes during meiosis I in oocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.01133"}], "href": "https://doi.org/10.7554/eLife.01133"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24192037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24192037"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Susanne Hellmuth, Laura Gómez-H, Alberto M Pendás, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Securin-independent regulation of separase by checkpoint-induced shugoshin-MAD2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-020-2182-3"}], "href": "https://doi.org/10.1038/s41586-020-2182-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32322060"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32322060"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "R Faridi, A U Rehman, R J Morell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations of SGO2 and CLDN14 collectively cause coincidental Perrault syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cge.12867"}], "href": "https://doi.org/10.1111/cge.12867"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27629923"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27629923"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Swathi Krishnan, Arne H Smits, Michiel Vermeulen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phospho-H1 Decorates the Inter-chromatid Axis and Is Evicted along with Shugoshin by SET during Mitosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2017.07.008"}], "href": "https://doi.org/10.1016/j.molcel.2017.07.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28781233"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28781233"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yuichiro Asai, Koh Fukuchi, Yuji Tanno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aurora B kinase activity is regulated by SET/TAF1 on Sgo2 at the inner centromere."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.201811060"}], "href": "https://doi.org/10.1083/jcb.201811060"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31527146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31527146"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ying Kao, Wen-Chiuan Tsai, Ssu-Han Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Shugosin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-021-97119-4"}], "href": "https://doi.org/10.1038/s41598-021-97119-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34535705"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34535705"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Min Deng, Shaohua Li, Jie Mei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes (Basel) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/genes12060876"}], "href": "https://doi.org/10.3390/genes12060876"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34200261"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34200261"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Tingting Lv, Dongwei He, Xiaokuan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.204443"}], "href": "https://doi.org/10.18632/aging.204443"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36566018"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36566018"}]}]}]}
|
| NCBI Gene ID | 151246 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SGO2 has 2,516 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 35 datasets.
Click the + buttons to view associations for SGO2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SGO2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with SGO2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SGO2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SGO2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of SGO2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SGO2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing SGO2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SGO2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of SGO2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SGO2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with SGO2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SGO2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SGO2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SGO2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SGO2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of SGO2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SGO2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SGO2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SGO2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SGO2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of SGO2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SGO2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SGO2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving SGO2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SGO2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of SGO2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of SGO2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SGO2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SGO2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of SGO2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of SGO2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SGO2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SGO2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SGO2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SGO2 protein from the WikiPathways Pathways 2024 dataset. | |